Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries presented its first quarter 2023 financial results on May 10, 2023. The presentation includes financial performance metrics, business updates on branded and generic pharmaceutical products including AUSTEDO, AJOVY, and COPAXONE, and forward-looking statements on company strategy and operational challenges.
investor_presentation
37 Pages
earnings
20 Pages
Motorola Solutions
Enable Midstream Partners Q3 2016 Conference Call
earningsearnings
26 Pages
Enable Midstream Partners
Wolverine Worldwide Q2 2024 Investor Presentation
earningsearnings
24 Pages
Wolverine Worldwide